Biomed Research And Analysis Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
About Biomed Research And Analysis
Biomed Research And Analysis Private Limited (BRAAPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2014 and has a history of Ten years and four months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Singh and Sandeep Bisen serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100UP2014PTC066387
-
Company No.
066387
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 2014
-
Date of AGM
24 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Biomed Research And Analysis Private Limited offer?
Biomed Research And Analysis Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Generic Pharmaceuticals.
Who are the key members and board of directors at Biomed Research And Analysis?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Singh
|
Director | 01-Oct-2014 | Current |
|
Sandeep Bisen
|
Director | 26-Jun-2023 | Current |
Financial Performance of Biomed Research And Analysis.
Biomed Research And Analysis Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomed Research And Analysis?
In 2017, Biomed Research And Analysis had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biomed Research And Analysis?
Unlock and access historical data on people associated with Biomed Research And Analysis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomed Research And Analysis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomed Research And Analysis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
